Article
FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
Pathology oncology research : POR - 1 Jan 2023
Behnke Anke, Cayre Anne, De Maglio Giovanna, Giannini Giuseppe, Habran Lionel, Tarsitano Marina, Chetta Massimiliano, Cappellen David, Lespagnol Alexandra, Le Naoures Cecile, Massazza Gabriella, Destro Annarita, Bonzheim Irina, Rau Achim, Battmann Achim, Kah Bettina, Watkin Emmanuel, Hummel Michael
Abstract excerpt
Accurate testing for epidermal growth factor receptor (EGFR) variants is essential for informing treatment decisions in non-small cell lung cancer (NSCLC). Automated diagnostic workflows may allow more streamlined initiation of targeted treatments, where appropriate, while comprehensive variant analysis is ongoing. FACILITATE, a real-world, prospective, multicenter, European study, evaluated performance and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.